Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Assets (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Current Assets for 12 consecutive years, with $561.3 million as the latest value for Q1 2026.

  • For Q1 2026, Current Assets rose 117.57% year-over-year to $561.3 million; the TTM value through Mar 2026 reached $561.3 million, up 117.57%, while the annual FY2025 figure was $614.8 million, 91.89% up from the prior year.
  • Current Assets hit $561.3 million in Q1 2026 for Wave Life Sciences, down from $614.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $614.8 million in Q4 2025 and bottomed at $98.5 million in Q4 2022.
  • Average Current Assets over 5 years is $247.0 million, with a median of $215.5 million recorded in 2025.
  • Year-over-year, Current Assets crashed 39.39% in 2022 and then soared 138.87% in 2023.
  • Wave Life Sciences' Current Assets stood at $98.5 million in 2022, then skyrocketed by 138.87% to $235.4 million in 2023, then skyrocketed by 36.12% to $320.4 million in 2024, then surged by 91.89% to $614.8 million in 2025, then decreased by 8.71% to $561.3 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods came in at $561.3 million, $614.8 million, and $215.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.